Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 237.65 | 240.91 |
| 52-Wk Range | - | - |
| Last Close | 238.68 |
| Mkt Cap (m) | 137,134.55 |
| Dividend yield | 2.82 |
| ISIN | US0311621009 |
| Volume | 2,149,013.00 |
| Exchange Venue | NAS |
Company Profile
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Key Information
| Price/Earning | 19.77 |
| Price/Book | 14.68 |
| Price/Sales | 5.57 |
| P/CF | 13.38 |
| Rev Growth (3 year avg) | 3.62 |
| EPS Growth (3 year avg) | 0.66 |
| Operating Margin % | 35.95 |
| Net Margin % | 28.57 |
| Return on Equity | 76.13 |
| Debt/Equity | 3.51 |
Documents
Prospectus
| en 15/04/2021 |
Annual Report
| en 31/12/2020 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Revenue (m) | 21,662.00 | 22,991.00 | 22,849.00 | 23,747.00 | 23,362.00 | 25,424.00 |
| Operating Income (m) | 8,470.00 | 9,794.00 | 9,973.00 | 10,263.00 | 9,674.00 | 9,139.00 |
| Net Income (m) | 6,939.00 | 7,722.00 | 1,979.00 | 8,394.00 | 7,842.00 | 7,264.00 |
| Basic EPS | 9.15 | 10.32 | 2.71 | 12.70 | 12.96 | 12.40 |
| Avg. Diluted Shares Outstanding (m) | 766.00 | 754.00 | 735.00 | 665.00 | 609.00 | 590.00 |
Balance Sheet
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Current Assets (m) | 38,518.00 | 46,010.00 | 49,476.00 | 37,618.00 | 18,440.00 | 21,144.00 |
| Non Current Assets (m) | 33,058.00 | 31,616.00 | 30,478.00 | 28,798.00 | 41,267.00 | 41,804.00 |
| Total Assets (m) | 71,576.00 | 77,626.00 | 79,954.00 | 66,416.00 | 59,707.00 | 62,948.00 |
| Current Liabilities (m) | 8,667.00 | 11,204.00 | 9,020.00 | 13,488.00 | 12,835.00 | 11,653.00 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 28,083.00 | 29,875.00 | 25,241.00 | 12,500.00 | 9,673.00 | 9,409.00 |
Cash Flows
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Operating Cash Flows (m) | 9,077.00 | 10,354.00 | 11,177.00 | 11,296.00 | 9,150.00 | 10,497.00 |
| Capital Expenditure (m) | -649.00 | -837.00 | -664.00 | -738.00 | -618.00 | -608.00 |
Figures are quoted in USD unless stated otherwise
1.56 (0.65%)
$
240.24
Last Price
© 2021 MeDirect Bank (Malta) plc. All rights reserved.
MeDirect Bank (Malta) plc, company registration number C34125, is licensed to undertake the business of banking in terms of the Banking Act (Cap. 371) and investment services under the Investment Services Act (Cap. 370). MeDirect Bank (Malta) plc is regulated by the Malta Financial Services Authority as a Credit Institution under the Banking Act 1994.